0001558370-21-010617 Sample Contracts

IOVANCE BIOTHERAPEUTICS, INC. 2018 EQUITY INCENTIVE PLAN NONQUALIFIED STOCK OPTION AWARD AGREEMENT

Nonqualified Stock Option Award Agreement • August 5th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Nonqualified Stock Option Award Agreement
• Filed
  August 5th, 2021
• Company
  Iovance Biotherapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS NONQUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), is entered into as of [ ] (the “Date of Grant”), by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”) on behalf of itself and its Affiliates, and [ ] (the “Participant”). Capitalized terms used in this Agreement and not otherwise defined herein have the meanings ascribed to such terms in the Iovance Biotherapeutics, Inc. 2018 Equity Incentive Plan, as amended, restated or otherwise modified from time to time in accordance with its terms (the “Plan”).

PUBLIC HEALTH SERVICE AMENDED AND RESTATED PATENT LICENSE AGREEMENT ‒ EXCLUSIVE

Patent License Agreement • August 5th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • District of Columbia

• Contract Type
  Patent License Agreement
• Filed
  August 5th, 2021
• Company
  Iovance Biotherapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  District of Columbia

This Amended and Restated Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options).